This €1.6 Million financing will allow MSInsight to finalize MSIcare's technological development, demonstrate its performance ...

New research shows that fecal transplants may boost the effectiveness of cancer immunotherapy drugs called PD-1 inhibitors.

A humble yet groundbreaking clinical trial at Memorial Sloan Kettering Cancer Center (MSK) has achieved unprecedented results ...

As a tumor-agnostic biomarker, MSI is relevant to a vast majority of cancer patients, with up to 13 million individuals worldwide potentially eligible for this diagnostic approach each year.

As global markets grapple with inflation concerns and trade policy uncertainties, Asian tech stocks are capturing attention amid shifting economic dynamics. In this environment, identifying ...

Tim Story, a Mississippi football coach, was given months to live after late-stage colon cancer. He enrolled in a clinical ...

This €1.6 Million financing will allow MSInsight to finalize MSIcare’s technological development, demonstrate its performance in various types of cancer, and initiate the regulatory clinical ...

Mar. 12, 2025 — Metastatic melanoma is the most aggressive form of skin cancer. In an effort to achieve targeted therapy for metastatic melanoma, researchers recently developed a new radioactive ...

Astellas Pharma’s strong pipeline and revenue growth support a positive outlook. See why ALPMF stock is a "Buy," driven by ...